{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:52:52Z","timestamp":1761929572421},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute of Health","award":["P51 RR000164"],"award-info":[{"award-number":["P51 RR000164"]}]},{"name":"Department of Health and Human Services"},{"name":"NIH\/NCRR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.antiviral.2011.11.013","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T21:35:45Z","timestamp":1323207345000},"page":"204-208","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model"],"prefix":"10.1016","volume":"93","author":[{"given":"Daniel","family":"Verreault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satheesh K.","family":"Sivasubramani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Talton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara A.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie Z.","family":"Killeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Didier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston A.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad J.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2011.11.013_b0005","doi-asserted-by":"crossref","first-page":"11084","DOI":"10.1128\/JVI.00423-07","article-title":"Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox","volume":"81","author":"Adams","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2011.11.013_b0010","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1099\/vir.0.81299-0","article-title":"Replication kinetics of Marek\u2019s disease vaccine virus in feathers and lymphoid tissues using PCR and virus isolation","volume":"86","author":"Baigent","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.11.013_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.11.013_b0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/1099-1263(200007\/08)20:4<273::AID-JAT657>3.0.CO;2-X","article-title":"Allometric respiration\/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans","volume":"20","author":"Bide","year":"2000","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.antiviral.2011.11.013_b0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(01)00220-0","article-title":"Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir","volume":"54","author":"Bray","year":"2002","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.antiviral.2011.11.013_b0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2011.11.013_b0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0165-6147(02)02091-6","article-title":"Cidofovir in the therapy and short-term prophylaxis of poxvirus infections","volume":"23","author":"De Clercq","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2011.11.013_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(02)00008-6","article-title":"Cidofovir in the treatment of poxvirus infections","volume":"55","author":"De Clercq","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.11.013_b0045","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2009.06.105","article-title":"Evaluation of the efficacy of modified vaccinia Ankara (MVA)\/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model","volume":"27","author":"Garza","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.11.013_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-126-4-199702150-00001","article-title":"Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial","volume":"126","author":"Lalezari","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.antiviral.2011.11.013_b0055","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1099\/vir.0.81331-0","article-title":"Complete coding sequences of the rabbitpox virus genome","volume":"86","author":"Li","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2011.11.013_b0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/AAC.00708-08","article-title":"Pharmacodynamics of cidofovir for vaccinia virus infection in an in vitro hollow-fiber infection model system","volume":"53","author":"McSharry","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.11.013_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2008.03.005","article-title":"Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model","volume":"79","author":"Nalca","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2011.11.013_b0070","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2011.11.013_b0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3201\/eid0802.010164","article-title":"Public health assessment of potential biological terrorism agents","volume":"8","author":"Rotz","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2011.11.013_b0080","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/AAC.47.9.2933-2937.2003","article-title":"Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge","volume":"47","author":"Roy","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2011.11.013_b0085","series-title":"Biodefense: Research Methodology and Animal Models","first-page":"61","article-title":"Infectious disease aerobiology: aerosol challenge methods","author":"Roy","year":"2005"},{"key":"10.1016\/j.antiviral.2011.11.013_b0090","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/v2092096","article-title":"Use of the aerosol rabbitpox virus model for evaluation of anti-poxvirus agents","volume":"2","author":"Roy","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2011.11.013_b0095","first-page":"453","article-title":"Experimental respiratory infection with poxviruses. I. Clinical virological and epidemiological studies","volume":"47","author":"Westwood","year":"1966","journal-title":"Br. J. Exp. Pathol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211005146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:20:00Z","timestamp":1588814400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211005146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0166354211005146"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.11.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}